24/7 Market News Publishes Report on Recent Spider Silk Production Breakthroughs Featuring Kraig Biocraft Laboratories
DENVER, Colo., May 10, 2024 (247marketnews.com)- Kraig Biocraft Laboratories (OTCQB:KBLB) and DuPont’s (NYSE:DD) are mentioned.
Spider Silk, the “Holy Grail” of Fibers, is coming and should Immediately Impact Several Significant Materials Sectors
The global mundane silk market is approximately $27.6 billion USD, as of 2023, and is expected to reach $52.6 billion, by 2029, according to Allied Market Research.
Spider silk is the toughest, which is a combination of strength and elasticity, fiber known to man.
Kraig Biocraft Laboratories (OTCQB:KBLB) is pioneering the production of genetically bioengineered spider silk, using silkworms modified to spin spider silk cocoons that can be harvested in commercial quantities.
Kraig Labs is employing existing conventional silk production and processing infrastructure to expedite expansion of its global production capabilities through partnerships and joint ventures.
Approximately 30 countries produce mundane silk, led by China, India, Japan, Thailand, Vietnam, and Brazil.
However, before Kraig Labs’ bioengineered spider silk breakthroughs, there was no way to mass produce a high-quality version of this super fiber.
Spider silk’s tensile strength is comparable to high-grade steel and even stronger, in some cases, yet it elasticity allows it to stretch up to 5 times its length without breaking, so Kraig Labs’ Dragon Silk is even tougher than Kevlar, DuPont’s (NYSE:DD) antiballistic industry leading fiber.
Spider silk’s diverse potential applications should contribute to the growth of its future market value. It’s high-performance properties make it highly desired across various sectors including automotive, defense, healthcare, and textiles. For instance, in the automotive and defense sectors, spider silk’s high resilience and robustness make it an ideal material for manufacturing lighter and stronger components, such as bulletproof vests and other protective gear. The healthcare sector has experimented with innovative uses of spider silk, from biocompatible surgical sutures to other medical implants, leveraging its unique properties for various medical applications (Emergen Research)
The move towards producing spider silk at competitive costs could make it a viable alternative for Kevlar, plastics and other materials, especially considering its superior strength and biodegradability, but that transition could be expedited by the global focus on sustainability.
Non-Toxic Production: The production processes for many high-performance materials can be hazardous, involving toxic chemicals that pose health risks to workers. Biologically produced spider silk eliminates the need for harmful solvents and chemicals, promoting safer working conditions and improving the overall quality of life for those involved in the production chain.
Kraig Labs’ bio-degradable spider silk could significantly impact several markets by providing a sustainable alternative to traditional materials.
- Wound Care: The global wound care market is extensive, with the demand driven by increasing cases of chronic wounds like diabetic ulcers and the rising number of surgeries. The market was valued at approximately $22.3 billion in 2023 and is expected to grow to around $31.7 billion by 2032, with a CAGR of about 4.51% during 2024-2032.
- Textiles: While specific figures for eco-friendly or biodegradable textiles are less delineated, the global textile market size itself offers a perspective on potential. The market was valued at around $1000 billion in 2020 and is expected to grow substantially by the end of the decade, influenced by trends towards sustainability and innovative materials.
- Medical Devices (specifically for wound care): This segment includes products like biodegradable sutures and meshes, where spider silk’s strength and compatibility could be particularly valuable. The advanced wound care products segment, a part of this market, is expected to see significant growth driven by innovations and an aging population susceptible to chronic wounds.
- Protective Clothing: Including military and law enforcement gear, the market for personal protective equipment was valued at $52.7 billion in 2019 and is projected to reach $85.72 billion by 2027, potentially benefiting from materials like spider silk that offer high strength and flexibility.
*Grand View Research, Fortune Business Insights, Markets and Markets (source)
The integration of Kraig’s biodegradable spider silk into these markets could help reduce environmental impact significantly, replacing non-renewable, non-biodegradable materials like nylon and Kevlar. Moreover, the use of biodegradable materials aligns well with increasing regulatory and consumer demand for sustainable products, addressing several Environmental, Social, and Governance (ESG) concerns.
While specific financial metrics for Kraig Labs are not detailed in this report, the company’s investment appeal is enhanced by its innovative edge and potential to disrupt large, established markets with biodegradable alternatives. Financial incentives from governments and interest from industries seeking green alternatives could provide substantial revenue streams.
When Kraig Labs achieves its first commercial-size spider silk production run, the added value should be substantial, especially considering the following factors:
- Market Positioning: Brining the first commercially viable bioengineered spider silk to market adds to Kraig Labs’ current leadership position in the next generation of advanced materials. This strengthened position should command premium pricing, especially in high-value markets like medical devices, aerospace, and defense.
- Product Differentiation: Spider silk’s unique properties—such as its strength, flexibility, and biodegradability—offer significant advantages over traditional materials. This differentiation could allow Kraig Labs to penetrate various markets deeply, from textiles and apparel to more being specialized applications like surgical sutures and bulletproof vests.
- Sustainability Appeal: Given the increasing consumer and corporate focus on sustainability, Kraig Labs’ ecofriendly spider silk could attract substantial interest from industries looking to improve their environmental footprint. This sustainability aspect could also open government subsidies or tax incentives, further enhancing its commercial value.
- Scalability and Cost Efficiency: If Kraig Labs demonstrates that its spider silk can be produced on a commercial scale at a cost competitive with other high-performance fibers, this could rapidly accelerate adoption and increase the company’s market share in the materials sector.
- Intellectual Property and Licensing: Many spider silk-based technologies will be patented, providing Kraig Labs with additional revenue streams through licensing agreements.
- Collaborations: Commercial production could lead to strategic partnerships with major brands in various industries, enhancing Kraig Labs’ market reach and application spectrum.
Assuming successful scaling and market acceptance, for these fibers, the move to commercial production could significantly enhance Kraig Labs’ market capitalization, potentially by hundreds of millions of dollars, or more, depending on the scope and scale.
Kraig Labs just announced the completion of successful spring production trials. The company exclaimed, “These trials proved that the Company’s BAM-1 recombinant spider silk hybrids are ready for rapid production expansion. Simply stated, this has been the most fruitful and successful production cycle in the Company’s history.”
Observation and screening conducted throughout all phases of production exceeded all expectations for health and vigor within the colony. Not a single instance of disease or infection was detected at any point during the entire cycle. This result surprised local sericulture experts observing the trials. Working with mundane silkworms, they had never experienced an entire production cycle from egg to egg without any disease in a batch of thousands of silkworms.
“The BAM-1 parental lines have proven to be the strongest and most resilient we have ever fielded,” said Company founder and CEO, Kim Thompson. “This production run greatly exceeded our targets and has prepared us for the next phase of our business plan. With these production trials successfully concluded, we are now aggressively implementing the next phase of our business plan, which will expand our operations and target multiple production locations in multiple countries.”
Kraig Biocraft Laboratories’ spring production trials mark a groundbreaking moment in the field of material science and biotechnology. The company’s success in developing BAM-1 recombinant spider silk hybrids demonstrates not only the viability of their innovative approach but also sets the stage for significant scaling and commercial expansion. Thompson’s remarks underscore the importance of this milestone, highlighting the exceptional health and resilience of the BAM-1 lines throughout the production cycle—a feat never before seen by industry experts and a testament to the robustness of Kraig Labs’ genetic engineering capabilities.
This success propels Kraig Labs into the next phase of their strategic plan, which involves expanding operations across multiple countries. By doing so, they are not just increasing their production capacity but are also setting a new standard for the production of sustainable and high-performance materials. The implications of this expansion are profound, promising to meet the increasing demands for environmentally friendly materials in various industries worldwide. As Kraig Labs moves forward with its ambitious plans, it remains a key player to watch in the revolution of sustainable materials.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
24/7 MARKET NEWS, INC Disclaimer
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release. 24/7 market news 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. 247market news expects to receive compensation for ongoing coverage of Kraig Labs, which could be up to twenty -five thousand dollars per month from Karolus, who is contracted directly from the company, for the next six months. The Editor holds shares previously disclosed from more than 10 years ago which are not on deposit or tradable. Neither Karolus nor 24/7 are trading in Kraig labs stock and would immediately update this disclosure if that were to change. 24/7 has been covering Kraig Labs for years and will continue to do for the foreseeable future. 247 market news is being paid for editorials and investor traffic to the company news.
This post contains sponsored content. The content is for informational purposes only and is not intended to be investing advice.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, bad company financing or other move can turn gains into losses.
Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.
Remove emotional and psychological biases and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in the mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Please go https://247marketnews.com/disclaimer/ for further information.
CONTACT:
24/7 Market News
Editor@247marketnews.com